Digital Pathology News and Research

RSS

$4.8 million grant supports research on TDP-43 misfolding in neurodegenerative diseases

A new $4.8 million grant will support researchers from Indiana University School of Medicine and the Medical Research Council Laboratory of Molecular Biology to study how human neurodegenerative diseases are affected by the misfolding of the protein TDP-43.

23 Apr 2024

Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance

A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.

16 Apr 2024

Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysis

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans. It has been given a CE and UKCA mark for the European Union and United Kingdom respectively, meaning it is cleared to be used in those markets.

24 Mar 2024

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and others, have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field.

14 Feb 2024

New AI tool spotlights hidden cancers for better diagnosis

A new artificial intelligence tool that interprets medical images with unprecedented clarity does so in a way that could allow time-strapped clinicians to dedicate their attention to critical aspects of disease diagnosis and image interpretation.

2 Jan 2024

Combining AI, ctDNA, and histopathology for improved treatment stratification in colorectal cancer

Combining artificial intelligence-generated digital pathology tools, conventional histopathological assessment and circulating tumor DNA (ctDNA) analysis can improve treatment stratification of patients with colorectal cancer after surgery.

1 Dec 2023

New artificial intelligence algorithms facilitate diagnosis of difficult cancers

New artificial intelligence algorithms are developed to facilitate the diagnosis and treatment of cancerous tumors that are difficult to interpret clinically.

27 Nov 2023

Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

In a peer-reviewed study published today in Nature Communications, a team of scientists from French-American techbio Owkin and pathology labs in France present a blind validation of MSIntuit CRC, a first-in-class AI-driven digital pathology diagnostic developed by Owkin, as a pre-screening tool aimed at optimizing the precision of diagnosis and treatment of colorectal cancer.

7 Nov 2023

3DHISTECH at the Comenius University in Slovakia

The Ministry of Health of Slovakia, in cooperation with the Slovak Society of Pathologists, organized a Presentation Day of Digital Pathology Solutions at Comenius University in Bratislava.

From 3DHISTECH Ltd. 25 Sep 2023

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation Incubator in Budapest to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions.

From 3DHISTECH Ltd. 25 Sep 2023

Digital pathology technology set to transform medical diagnosis

Patients will receive faster and more accurate pathology results following a decade-long research project that is set to transform medical diagnosis.

20 Jul 2023

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

3DHISTECH is thrilled to announce its recent collaboration with Quantmetry.

From 3DHISTECH Ltd. 22 Jun 2023

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

3DHISTECH is thrilled to announce its recent collaboration with Quantmetry.

22 Jun 2023

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia have identified new biomarkers for non-small cell lung cancer, the most common lung cancer.

20 Jun 2023

Innovative approach for detecting pre-cancerous lesions using large, high-res images

A new study presents an innovative approach to the crucial detection of pre-cancerous lesions using large, high-res images.

1 Jun 2023

Unraveling Nature's Complexity with Molecular Imaging

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Ron Heeran, a speaker at the 2023 James L. Waters Symposium.

From Pittcon 1 May 2023

When mass spectrometry redefines molecular biology and biochemistry – the future of spatial omics

In this interview, Bruker speaks with Ramon Sun on the topic of SpatialOMx - a field that is currently experiencing great changes. Dive in to discover how Bruker will rise to the challenge.

From Bruker Life Sciences Mass Spectrometry 17 Mar 2023

Veterans’ health administration expands deployment of Mikroscan Systems

Mikroscan Technologies, innovators and manufacturers of live robotic microscopy and whole-slide imaging (WSI) systems, announces that it has expanded its relationship with the Veterans’ Administration through the multi-system sale of its SL5-20 Real-Time Telemicroscopy and Digital Pathology systems.

From Mikroscan Technologies 14 Mar 2023

What is the role of B cells in breast cancer pathology?

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer.

1 Mar 2023

Fujifilm announces asset purchase agreement with Inspirata, Inc. to acquire the company’s digital pathology business

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced the company has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc. Upon completion of this agreement, Inspirata's Dynamyx® digital pathology technology, employees and customers will become part of Fujifilm.

From FUJIFILM Corporation 20 Dec 2022

Digital Pathology News and Research

$4.8 million grant supports research on TDP-43 misfolding in neurodegenerative diseases

Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance

Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysis

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

New AI tool spotlights hidden cancers for better diagnosis

Combining AI, ctDNA, and histopathology for improved treatment stratification in colorectal cancer

New artificial intelligence algorithms facilitate diagnosis of difficult cancers

Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

3DHISTECH at the Comenius University in Slovakia

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Digital pathology technology set to transform medical diagnosis

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Innovative approach for detecting pre-cancerous lesions using large, high-res images

Unraveling Nature's Complexity with Molecular Imaging

When mass spectrometry redefines molecular biology and biochemistry – the future of spatial omics

Veterans’ health administration expands deployment of Mikroscan Systems

What is the role of B cells in breast cancer pathology?

Fujifilm announces asset purchase agreement with Inspirata, Inc. to acquire the company’s digital pathology business

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News